Pharmaceutical Licensing Group Limited - Limited company - abbreviated - 11.9

Pharmaceutical Licensing Group Limited - Limited company - abbreviated - 11.9


04411527 1.7.14 30.6.15 30.6.15 Company accounts Private Limited Company FY true false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure044115272014-06-30044115272015-06-30044115272014-07-012015-06-30044115272013-06-30044115272013-07-012014-06-30044115272014-06-3004411527ns12:England2014-07-012015-06-3004411527ns14:PoundSterling2014-07-012015-06-3004411527ns7:Director12014-07-012015-06-3004411527ns7:Director22014-07-012015-06-3004411527ns7:Director32014-07-012015-06-3004411527ns7:Director42014-07-012015-06-3004411527ns7:CompanySecretary2014-07-012015-06-3004411527ns7:RegisteredOffice2014-07-012015-06-3004411527ns7:EntityAccountantsOrAuditors2014-07-012015-06-3004411527ns5:FixturesFittings2014-07-012015-06-30
REGISTERED NUMBER: 04411527 (England and Wales)















Abbreviated Unaudited Accounts for the Year Ended 30 June 2015

for

Pharmaceutical Licensing Group Limited

Pharmaceutical Licensing Group Limited (Registered number: 04411527)






Contents of the Abbreviated Accounts
for the Year Ended 30 June 2015




Page

Company Information 1

Abbreviated Balance Sheet 2

Notes to the Abbreviated Accounts 4

Pharmaceutical Licensing Group Limited

Company Information
for the Year Ended 30 June 2015







DIRECTORS: Miss A Dugdale
Dr E Evans
Mr S A Jarvis
Dr C Wilson





SECRETARY: Mr S A Jarvis





REGISTERED OFFICE: The Red House Kingswood Park
Bonsor Drive
Kingswood
Tadworth
Surrey
KT20 6AY





REGISTERED NUMBER: 04411527 (England and Wales)





ACCOUNTANTS: Wilson Partners Limited
Chartered Accountants
5a Frascati Way
Maidenhead
Berkshire
SL6 4UY

Pharmaceutical Licensing Group Limited (Registered number: 04411527)

Abbreviated Balance Sheet
30 June 2015

30.6.15 30.6.14
Notes £    £   
FIXED ASSETS
Tangible assets 2 437 -

CURRENT ASSETS
Debtors 41,780 40,537
Cash at bank 120,136 138,456
161,916 178,993
CREDITORS
Amounts falling due within one year (33,728 ) (20,933 )
NET CURRENT ASSETS 128,188 158,060
TOTAL ASSETS LESS CURRENT
LIABILITIES

128,625

158,060

RESERVES
Income and expenditure account 128,625 158,060
128,625 158,060

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2015.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2015 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the
Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as
at the end of each financial year and of its surplus or deficit for each financial year in accordance with
the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the
Companies Act 2006 relating to financial statements, so far as applicable to the company.

Pharmaceutical Licensing Group Limited (Registered number: 04411527)

Abbreviated Balance Sheet - continued
30 June 2015


The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the Board of Directors on 23 November 2015 and were signed
on its behalf by:




Mr S A Jarvis - Director



Dr C Wilson - Director


Pharmaceutical Licensing Group Limited (Registered number: 04411527)

Notes to the Abbreviated Accounts
for the Year Ended 30 June 2015

1. ACCOUNTING POLICIES

Basis of preparing the financial statements
The accounts are prepared on a going concern basis as in the opinion of the directors the company
has sufficient finance available to it to meet its obligations as they fall due for the foreseeable
future, that is at least 12 months from the date of approval of the accounts.

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance
with the Financial Reporting Standard for Smaller Entities (effective April 2008).

Turnover
Turnover represents the value of goods and services under contracts, provided in the year, exclusive
of Value Added Tax, to the extent that there is a right to consideration and is recorded at the value
of consideration due.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings - 33% on cost

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed
at the balance sheet date, where transactions or events that result in an obligation to pay more or a
right to pay less tax in the future have occurred by the balance sheet date with certain limited
exceptions.

Deferred tax is calculated on an undiscounted basis at the tax rates that are expected to apply in the
periods in which the timing differences are expected to reverse, based on tax rates and laws enacted
or substantively enacted at the balance sheet date.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling
at the 30/06/2015 date. Transactions in foreign currencies are translated into sterling at the rate of
exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at
the operating result.

Pharmaceutical Licensing Group Limited (Registered number: 04411527)

Notes to the Abbreviated Accounts - continued
for the Year Ended 30 June 2015

2. TANGIBLE FIXED ASSETS
Total
£   
COST
At 1 July 2014 14,993
Additions 655
Disposals (9,863 )
At 30 June 2015 5,785
DEPRECIATION
At 1 July 2014 14,993
Charge for year 218
Eliminated on disposal (9,863 )
At 30 June 2015 5,348
NET BOOK VALUE
At 30 June 2015 437
At 30 June 2014 -